2m 2m 2m 2m 2m 2m 2m
Opus Genetics (IRD)
NASDAQ
$4.10-$0.10 (-2.36%)
Price as of Jun 03, 2026 6:28 PM EDT- $354.9MMarket Cap
- 295.05%1-Year Change
- BiotechnologyIndustry
Opus Genetics (IRD)
$4.10-$0.10 (-2.36%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 14.2M +29.15% | 11.0M -42.30% | 19.0M -52.20% | 39.9M +6,665.70% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 14.2M +29.15% | 11.0M -42.30% | 19.0M -52.20% | 39.9M +6,665.70% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -30.8M +14.75% | -26.9M +52.10% | -17.7M +22.97% | -14.4M -5.39% | |
Depreciation and Amortization Expense | 53,000 +430.00% | 10,000 +66.67% | 6,000 +50.00% | 4,000 0.00% | |
Total Operating Expenses | 52.8M -27.74% | 73.1M +146.74% | 29.6M +36.94% | 21.6M -7.17% | |
Operating Profit | -38.6M -37.82% | -62.1M +487.66% | -10.6M -157.96% | 18.2M +180.27% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -100,000 N/A | N/A N/A | 0 +100.00% | -9,000 +350.00% | |
Interest Income and Expense and Net | -100,000 N/A | 0 N/A | 0 +100.00% | -9,000 +350.00% | |
Total Nonoperating Income and Expense | 2.0M -55.50% | 4.5M +143.33% | 1.8M +13,221.43% | -14,000 -91.08% | |
Income before Taxes | -49.6M -13.80% | -57.5M +476.82% | -10.0M -154.79% | 18.2M +132.11% | |
Income Taxes | 0 N/A | 0 -100.00% | 12,000 -96.19% | 315,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -49.6M -13.80% | -57.5M +476.13% | -10.0M -155.83% | 17.9M +131.55% | |
Net Income from Continuing Operations Applicable to Common | -49.6M -13.80% | -57.5M +476.82% | -10.0M -154.79% | 18.2M +132.11% | |
Basic EPS and Net Income | -0.80 -62.79% | -2.15 +367.39% | -0.46 -151.11% | 0.90 +123.56% | |
Diluted EPS and Net Income | -0.80 -62.79% | -2.15 +367.39% | -0.46 -152.87% | 0.87 +122.77% | |
Basic Weighted Average Shares | 62.2M +132.91% | 26.7M +23.74% | 21.6M +8.32% | 19.9M +34.19% | |
Diluted Weighted Average Shares | 62.2M +132.91% | 26.7M +23.74% | 21.6M +4.82% | 20.6M +38.68% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 45.1M +48.71% | 30.3M -39.96% | 50.5M +18.45% | 42.6M +73.78% | |
Short-Term Investments | 0 -100.00% | 2,000 -86.67% | 15,000 -69.39% | 49,000 -77.63% | |
Cash and Cash Equivalents and Short-Term Investments | 45.1M +48.70% | 30.3M -39.97% | 50.5M +18.35% | 42.7M +72.44% | |
Total Current Assets | 50.0M +36.69% | 36.6M -32.14% | 53.9M +10.13% | 49.0M +87.92% | |
Accumulated Depreciation | N/A N/A | N/A N/A | 25,000 +31.58% | 19,000 +26.67% | |
Property and Plant and Equipment and Net | 199,000 -21.03% | 252,000 N/A | 0 -100.00% | 6,000 -40.00% | |
Total Long-Term Assets | 199,000 -21.03% | 252,000 N/A | 0 -100.00% | 6,000 -40.00% | |
Total Assets | 50.2M +36.30% | 36.9M -31.67% | 53.9M +10.12% | 49.0M +87.87% | |
Income Taxes Payable | N/A N/A | N/A N/A | 0 -100.00% | 315,000 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 600,000 N/A | 0 -100.00% | |
Total Current Liabilities | 7.8M -31.11% | 11.3M +179.44% | 4.0M +46.82% | 2.8M -28.59% | |
Total Long-Term Debt | 1.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 27.1M N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Liabilities | 34.9M +208.94% | 11.3M +179.44% | 4.0M +46.82% | 2.8M -28.59% | |
Retained Earnings | -188.6M +35.68% | -139.0M +70.62% | -81.5M +13.97% | -71.5M -20.02% | |
Total Stockholders Equity | 15.3M +128.26% | 6.7M -86.53% | 49.9M +7.93% | 46.2M +108.08% | |
Total Shares Outstanding | 69.9M +121.36% | 31.6M +31.68% | 24.0M +14.94% | 20.9M +10.69% | |
Cash Flow | |||||
Cash from Operating Activities | -35.3M +37.84% | -25.6M +2,200.00% | -1.1M -107.77% | 14.3M +173.90% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 0 -100.00% | 1.2M N/A | 0 N/A | 0 +100.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 50.0M +1,095.01% | 4.2M -53.38% | 9.0M +137.16% | 3.8M -86.29% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -271.90% -51.85% | -564.72% +918.40% | -55.45% -221.24% | 45.74% +101.19% | |
Return on Assets | -113.86% -10.14% | -126.71% +553.08% | -19.40% -140.71% | 47.66% +118.39% | |
Return on Equity | -449.36% +121.16% | -203.19% +878.13% | -20.77% -139.75% | 52.26% +104.04% | |
Revenue Growth | 29.15% +168.92% | -42.30% -18.97% | -52.20% -100.78% | 6,665.70% N/A | |
Current Ratio | 6.43 +98.43% | 3.24 -75.71% | 13.35 -24.99% | 17.79 +163.15% | |
Cash Ratio | 5.80 +115.87% | 2.68 -78.51% | 12.49 -19.32% | 15.49 +143.34% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow